DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst Meet15-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate(s)15-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Satish Reddy & G V Prasad15-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of earnings call conducted on May 7, 202413-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201513-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of confirmation/credit of shares from unclaimed suspense account in lieu of share certificate(s) reported lost/misplaced08-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication08-05-2024
Here's How Dr Reddy's Aims To Drive Growth In India Market
The pharmaceutical company's net profit jumped 36% to Rs 1,310 crore in the fourth quarter of fiscal 2024.08-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recordings of the Earnings call conducted on May 7, 202408-05-2024